Low Back Pain: Clinical Trials

55 trials for Low Back Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed, 9 unknown, 5 recruiting, 2 terminated. 55 Phase 1, 21 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 155Completed 36, Unknown 9, Recruiting 5, Terminated 2, Withdrawn 2, Enrolling by invitation 1
Phase 221Completed 15, Unknown 3, Enrolling by invitation 1, Terminated 1, Withdrawn 1

Follow Low Back Pain: new trials by email Literature Review of Low Back Pain trials Research Report on Low Back Pain

Trials (filtered) newest first · largest first

All 55 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adia Med of Winter Park LLC Lower Back Pain Research Study
Umbilical Cord Blood-Derived Stem Cells and Exosomes, Placebo IV - Chronic Mechanical Lower Back Pain, Lower Back Pain
Phase 1RecruitingAdia Med of Winter Park LLC1002026-06-162026-06-17
Hormones, Outcomes, and Pain Pathways in Exercise Study
Interventional Sports bra - Breast Pain, Mastalgia
Phase 1RecruitingUniversity of Houston1402026-05-172026-06-02
Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain
CNTX-3001, Placebo - Lower Back Pain
Phase 1RecruitingCentrexion Therapeutics162026-03-012026-03-23
Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults
Sodium Aescinate Tablets, Placebo - Low Back Pain, Paraspinal Muscle
Phase 1RecruitingXijing Hospital402026-03-012026-03-20
Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain
PIPE-791, Placebo - Chronic Osteoarthritis Pain, Chronic Low Back Pain
Phase 1CompletedContineum Therapeutics432025-02-042026-03-18
Comparison of the Efficacy of Diclofenac Sodium and Subcutaneous 5% Dextrose Injection in Low Back Pain.
5% dextrose prolotherapy, Diclofenac 75mg/ml - Low Back Pain, Mechanical
Phase 1 / Phase 2Enrolling by invitationAksaray University Training and Research Hospital1502024-07-152025-02-19
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
Lumbar Injections with 10cc's of Wharton's Jelly Allograft - Low Back Pain
Phase 1RecruitingR3 Stem Cell1002024-03-252024-04-11
Development and Evaluation of Computerized Chemosensory Based Orbitofrontal Networks Training for Treatment of Pain
Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) short burst paradigm, Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) long burst paradigm, Computerized Chemosensory-Based Orbitofrontal Cortex Training plus beta caryophyllene (CBOT-Plus) - Chronic Pain, Low Back Pain
Phase 1CompletedEvon Medics LLC862023-04-272024-01-23
Breathing and Attention Training for Chronic Low Back Pain
Breathing and Attention Training - Chronic Low-back Pain
Phase 1 / Phase 2CompletedUniversity of Florida292021-07-182024-06-10
Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy
Single bilateral intra-articular injection of allogeneic BM-MSCs for lumbar facet joint arthropathy - Facet-Mediated Low Back Pain
Phase 1CompletedMayo Clinic102020-04-282024-12-19
Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain
PP353, Placebo - Chronic Low-back Pain
Phase 1 / Phase 2CompletedPersica Pharmaceuticals Ltd432020-01-202026-03-27
Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain
SX600, Placebo - Lumbar Radiculopathy
Phase 1 / Phase 2TerminatedSpineThera Australia PTY LTD562019-11-042024-01-10
Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study
GTX 2/3, Placebo - Back Pain, Acute Pain
Phase 1 / Phase 2CompletedAlgenis SpA302019-10-112021-03-16
Application of LED Photobiomodulation in the Treatment of Chronic Low Back Pain
LED Photobiomodulation, Placebo LED Photobiomodulation - Low Back Pain
Phase 1 / Phase 2UnknownUniversity of Nove de Julho762019-08-012019-07-01
BOL-DP-o-04 in Patients With Low Back Pain and Sciatica
BOL-DP-o-04 + SCO, Placebo + SCO - Low Back Pain, Sciatica
Phase 1 / Phase 2CompletedBreath of Life International Pharma Ltd262018-11-272022-12-08
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
IDCT, Saline Solution, Sodium Hyaluronate - Degenerative Disc Disease
Phase 1CompletedDiscGenics, Inc.602018-02-262023-01-25
A Single Ascending Dose Study of Safety and Tolerability of STA363 Compared to Placebo in 15 Patients With Chronic Discogenic Low Back Pain
STA363, Placebo - Low Back Pain
Phase 1CompletedStayble Therapeutics152017-03-272020-02-18
Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain
Oxycodone or morphine sulfate immediate release (MSIR), Placebo Treatment - Low Back Pain
Phase 1CompletedBrigham and Women's Hospital352017-01-062026-02-04
Cayenne Pepper Cataplasm - Safety Study
Cayenne Pepper topical, Electrical stimulation, Massage - Low Back Pain
Phase 1 / Phase 2CompletedUniversity of Primorska302016-03-152018-02-20
New Approaches in Evaluating Patients' Response to Botulinum Toxins in the Treatment of Chronic Neck Pain and Back Pain
Botulinum Toxins - Cervicalgia, Low Back Pain
Phase 1UnknownVA Connecticut Healthcare System602016-03-012017-12-07

Showing 20 of 55. Sign in to see all of them.

Narrower conditions

Chronic Pain (6)  ·  Pain (5)  ·  Back Pain (4)  ·  Intervertebral Disc Degeneration (4)  ·  Sciatica (4)  ·  Motor Activity (3)  ·  Neck Pain (3)  ·  Acute Pain (2)  ·  Intervertebral Disc Displacement (2)  ·  Agnosia (1)  ·  Arthritis (1)  ·  Body Weight (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Chest Pain (1)

Broader conditions

Neurologic Manifestations (55)  ·  Pathological Conditions, Signs and Symptoms (55)  ·  Signs and Symptoms (55)  ·  Back Pain (51)  ·  Pain (50)  ·  Musculoskeletal Diseases (8)  ·  Nervous System Diseases (8)  ·  Bone Diseases (6)  ·  Spinal Diseases (6)  ·  Neuromuscular Diseases (5)  ·  Peripheral Nervous System Diseases (5)  ·  Mononeuropathies (4)  ·  Neuralgia (4)  ·  Pathologic Processes (4)  ·  Sciatic Neuropathy (4)

Interventions

Acupuncture Therapy (2)  ·  Cognitive Behavioral Therapy (2)  ·  Genes, mos (2)  ·  Manipulation, Spinal (2)  ·  Mindfulness (2)  ·  Sodium Chloride (2)  ·  Acetaminophen (1)  ·  Acupuncture, Ear (1)  ·  Anti-Bacterial Agents (1)  ·  Athletic Tape (1)  ·  Botulinum Toxins (1)  ·  Botulinum Toxins, Type A (1)  ·  Diclofenac (1)  ·  Electric Stimulation (1)  ·  Ergonomics (1)

Sponsors

University of Florida (3)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  National Center for Complementary and Integrative Health (NCCIH) (2)  ·  Red de Terapia Celular (2)  ·  The University of Queensland (2)  ·  University of Bologna (2)  ·  Adia Med of Winter Park LLC (1)  ·  Aksaray University Training and Research Hospital (1)  ·  Algenis SpA (1)  ·  Anglo-European College of Chiropractic (1)  ·  AstraZeneca (1)  ·  Baylis Medical Company (1)  ·  Breath of Life International Pharma Ltd (1)  ·  Brigham and Women's Hospital (1)  ·  Centrexion Therapeutics (1)

Countries

United States (25)  ·  Spain (4)  ·  Australia (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Italy (2)  ·  South Korea (2)  ·  Sweden (2)  ·  Austria (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Israel (1)

Top investigators

Aleksandra Zgierska, MD PhD (1)  ·  Alex F Manini, MD, MS, FACMT (1)  ·  Ana Paula A Rubira, master (1)  ·  Ana Sanchez, MD, PhD (1)  ·  Anthony Rosner, PhD (1)  ·  Avril Drummond, PhD (1)  ·  Bambi Alyagon, MSc (1)  ·  Bruce Vrooman, M.D. (1)  ·  Carol M Coole, MSc (1)  ·  Charles Nwaokobia (1)  ·  David C Noriega, MD, PhD (1)  ·  Duncan McHale, MBBS MRCP (1)  ·  Durval C Kraychet (1)

Results publications

PMID 10360702, PMID 10488513, PMID 11145807, PMID 11172169, PMID 12384756, PMID 12709856, PMID 12897484, PMID 15115710, PMID 15454701, PMID 15677041, PMID 16192528, PMID 16227895, PMID 16371894, PMID 16911795, PMID 17256032, PMID 17895350, PMID 19387178, PMID 19797305, PMID 21162726, PMID 21256073, PMID 21704784, PMID 23279658, PMID 24361109, PMID 26920137, PMID 26968850, PMID 27661661, PMID 28939263, PMID 29141662, PMID 29550099, PMID 30920244, PMID 31442616, PMID 35921598, PMID 36694217, PMID 38925869, PMID 39544354, PMID 41163019, PMID 41768986, PMID 42370792, PMID 8113928, PMID 9854752

NIH funding

1UG3NS123965-01 (1), 2015 (1), 2018 (1), R01AR084021 (1), R21AR055716 (1), R44NS125745 (1)